Leading Midwest Venture Conference Now Accepting Company Presentation Submissions
WASHINGTON, D.C. (June 12, 2007) -- The Biotechnology Industry Organization (BIO) is now accepting submissions for companies to present at the BIO Mid-America VentureForum 2007, the midwest venture conference for the bioscience, biofuel, medical device, and venture capital communities in the United States and Canada to be held September 24-26, 2007 in Milwaukee, Wis. at the Hyatt Regency Hotel.
Approximately 60 pre-screened bioscience and healthcare product, technology, device, diagnostics, and biofuel companies seeking early to late-stage funding will present their portfolios and platforms to an international audience of top venture capital firms and angel investors. Presenters will have the opportunity to build and develop relationships with investors, industry experts, analysts and other attendees.
All submissions will be reviewed by the BIO Mid-America VentureForum 2007 Advisory Board, which represents a cross-section of the leading bioscience and biofuel venture capital firms. Companies will be notified when they are selected to present. To request a presentation slot, please visit: http://bma.bio.org/opencms/bma/2007/presenting/presenting.jsp.
The BIO Mid-America VentureForum, the largest Midwest investor conference for life science firms, will be hosted by BIO, the Wisconsin Biotechnology and Medical Device Association, and eight additional Midwest bioscience associations. Now in its fifth year, the conference will feature workshops highlighting trends in the financial markets and challenges faced by bioscience, biofuel and medical technology companies, presentations from up to 60 bioscience, biofuels and medical device startups, a partnering system with on- and off-site database tools facilitating the evaluation of partnering opportunities and the scheduling of one-on-one meetings at the conference, and a variety of formal and informal networking opportunities.
For more information on the BIO Mid-America VentureForum, including information on hotel accommodations and conference registration, please visit: http://bma.bio.org/opencms/bma/2007/index.jsp.
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the annual BIO International Convention, the global event for biotechnology.